[HTML][HTML] p53 signaling in cancer progression and therapy

HE Marei, A Althani, N Afifi, A Hasan, T Caceci… - Cancer cell …, 2021 - Springer
The p53 protein is a transcription factor known as the" guardian of the genome" because of
its critical function in preserving genomic integrity. The TP53 gene is mutated in …

[HTML][HTML] Targeting p53 pathways: mechanisms, structures, and advances in therapy

H Wang, M Guo, H Wei, Y Chen - Signal transduction and targeted …, 2023 - nature.com
The TP53 tumor suppressor is the most frequently altered gene in human cancers, and has
been a major focus of oncology research. The p53 protein is a transcription factor that can …

[HTML][HTML] Mutant p53 in cancer progression and targeted therapies

G Zhu, C Pan, JX Bei, B Li, C Liang, Y Xu, X Fu - Frontiers in oncology, 2020 - frontiersin.org
TP53 is the most frequently mutated tumor suppressor gene in human cancer. The majority
of mutations of p53 are missense mutations, leading to the expression of the full length p53 …

TP53 in bone and soft tissue sarcomas

E Thoenen, A Curl, T Iwakuma - Pharmacology & therapeutics, 2019 - Elsevier
Genomic and functional study of existing and emerging sarcoma targets, such as fusion
proteins, chromosomal aberrations, reduced tumor suppressor activity, and oncogenic …

[HTML][HTML] P53: a guardian of immunity becomes its saboteur through mutation

AD Agupitan, P Neeson, S Williams, J Howitt… - International journal of …, 2020 - mdpi.com
Awareness of the importance of immunity in controlling cancer development triggered
research into the impact of its key oncogenic drivers on the immune response, as well as …

[HTML][HTML] Transcription factor p53 suppresses tumor growth by prompting pyroptosis in non-small-cell lung cancer

T Zhang, Y Li, R Zhu, P Song, Y Wei, T Liang… - Oxidative Medicine and …, 2019 - hindawi.com
Objective. To evaluate the effect of p53 on pyroptosis and its inhibitory role on tumor growth
in non-small-cell lung cancer (NSCLC). Methods. The correlation of p53 and pyroptosis was …

[HTML][HTML] Gain of function (GOF) mutant p53 in cancer—current therapeutic approaches

KA Roszkowska, A Piecuch, M Sady… - International Journal of …, 2022 - mdpi.com
Continuous development of personalized treatments is undoubtedly beneficial for oncogenic
patients' comfort and survival rate. Mutant TP53 is associated with a worse prognosis due to …

[HTML][HTML] Transition of amyloid/mutant p53 from tumor suppressor to an oncogene and therapeutic approaches to ameliorate metastasis and cancer stemness

S Sengupta, SM Ghufran, A Khan, S Biswas… - Cancer Cell …, 2022 - Springer
The tumor suppressor p53 when undergoes amyloid formation confers several gain-of-
function (GOF) activities that affect molecular pathways crucial for tumorigenesis and …

[HTML][HTML] TP53 Mutation Is a Prognostic Factor in Lower Grade Glioma and May Influence Chemotherapy Efficacy

H Noor, NE Briggs, KL McDonald, J Holst, O Vittorio - Cancers, 2021 - mdpi.com
Simple Summary Molecular biomarkers are utilised for the development of targeted therapy
and diagnostic or prognostic tools and in strategising therapeutic approaches as they may …

The potential roles of p53 signaling reactivation in pancreatic cancer therapy

A Ou, X Zhao, Z Lu - Biochimica et Biophysica Acta (BBA)-Reviews on …, 2022 - Elsevier
Globally, pancreatic cancer (PC) is a common and highly malignant gastrointestinal tumor
that is characterized by an insidious onset and ready metastasis and recurrence. Over …